Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer tremendous potential for use in engineering human tissues for regenerative therapy and drug screening.
when translating in vitro results to clinical studies and precluding hiPSC-derived cardiac tissues from therapeutic use in vivo. To address this, we have developed hybrid hydrogels comprised of decellularized porcine myocardial extracellular matrix (dECM) and reduced graphene oxide (rGO) to provide a more instructive microenvironment for proper cellular and tissue development. A tissue-specific protein profile was preserved post-decellularization, and through the modulation of rGO content and degree of reduction, the mechanical and electrical properties of the hydrogels could be tuned. Engineered heart tissues (EHTs) generated using dECM-rGO hydrogel scaffolds and hiPSC-derived cardiomyocytes exhibited significantly increased twitch forces at 14 days of culture and had increased the expression of genes that regulate contractile function. Similar improvements in various aspects of electrophysiological function, such as calcium-handling, action potential duration, and conduction velocity, were also induced by the hybrid biomaterial.
We also demonstrate that dECM-rGO hydrogels can be used as a bioink to print cardiac tissues in a high-throughput manner, and these tissues were utilized to assess the proarrhythmic potential of cisapride. Action potential prolongation and beat interval irregularities was observed in dECM-rGO tissues at clinical doses of cisapride, indicating that the enhanced maturation of these tissues corresponded well with a capability to produce physiologically relevant drug responses.
Cardiovascular disease (CVD) remains a leading cause of death for both men and women worldwide, with the economic costs of healthcare related to treatment or quality of life improvements forecasted to exceed $1 trillion per year in the United States alone by 2030 1, 2 . With the healthcare burden of CVD increasing every year, considerable research is devoted to engineering cardiac tissues to better understand the underlying disease pathologies, to screen potential pharmacological treatments, and to serve as implantable therapies. The non-proliferative nature of terminally differentiated cardiomyocytes has served as a bottleneck for such work, as obtaining sufficient numbers of cells for studies is ethically and logistically difficult. The advent of human induced pluripotent stem cells (hiPSCs) has somewhat ameliorated this issue since not only are hiPSCs readily obtainable and scalable in culture, hiPSC lines can now be generated from patients with specific disease phenotypes 3, 4 . However, cardiomyocytes differentiated from hiPSCs are phenotypically immature and behave more like cells at a neonatal, rather than adult, stage of development 5 . This reduces reliability when translating in vitro assay results to clinical studies, as immature cells do not accurately reproduce the pharmacological responses and disease progression of the native myocardium.
To address this issue with cardiomyocyte maturity, various strategies have been studied in the field. For examples, studies have demonstrated that preconditioning of engineered cardiac tissues with specific biochemical, mechanical, and electrical stimulation regimes elicited beneficial effects on overall tissue function and maturation [6] [7] [8] . However, these techniques can be limited by their requirement for the integration of complex hardware and software, thereby resulting in potential difficulties with platform adaptability and in increasing experimental throughput. Alternatively, improved maturity can be potentially achieved by exploring attempts to recapitulate the myocardial extracellular matrix (ECM) that defines the architecture, signaling, and biomechanics of cardiomyocytes in vivo 9, 10 , and by utilizing engineered ECMs, mature tissues could be generated across a variety of existing platforms. Recent advances in developing threedimensional (3D) matrices have been able to better reproduce this cell niche; however, overall cardiomyocyte and engineered cardiac tissue maturity is still at suboptimal levels due to limitations with the scaffolds and platforms that are currently available. Naturally-derived polymers typically used to engineer 3D tissues, such as fibrin and collagen, offer good biocompatibility and biochemical similarity to in vivo systems. In particular, decellularized extracellular matrices (dECM) are able to largely preserve the tissue-specific biochemical makeup of the tissues that they are derived from 11 . The poor mechanical and electrical properties of these polymers, however, often hampers their ability to replicate the tissue microenvironment. Synthetic materials on the other hand, offer better control over their physical and chemical characteristics, but their bioactivity is often non-existent without further modification. Perhaps the most interesting exceptions are highly-electroconductive materials, such as carbon nanotubes 12, 13 , graphene derivatives 14, 15 , and gold 16, 17 , that have been found to impart beneficial effects on the growth and maturation of a variety of cell types and have recently gained increasing prominence in the field of tissue engineering.
Here, we report on the development of hybrid hydrogels that are comprised of reduced graphene oxide (rGO) dispersed within decellularized myocardial extracellular matrices (dECM).
By leveraging the advantages offered by rGO with regards to controlling properties such as stiffness and electroconductivity while maintaining the bioactivity inherent with dECM, this new material can advance the capability to engineer 3D human cardiac tissues that are more physiologically-representative of the native myocardium.
Results

Synthesis and characterization of dECM-rGO composite hydrogels with tunable mechanical
and electrical properties. The two primary components of the dECM-rGO composite hydrogels used in this study were prepared by means of parallel processes (Fig. 1a) . Left ventricular myocardium from freshly-harvested porcine hearts were decellularized using an established method that has been previously demonstrated to produce dECM in which the majority of cellular components have been removed, while still preserving the collagens and glycosaminoglycans (GAGs) originally present in the tissue 18 . As one of the stated benefits of utilizing dECM as a scaffold material is its recapitulation of the native tissue microenvironment, further analysis of its biochemical makeup post-decellularization was conducted using liquid chromatography tandem mass spectrometry (LC-MS/MS). Several produced batches of dECM were analyzed for key matrix proteins: collagens I -IV, fibronectin, and laminin ( Fig. 1b) . While batch-to-batch variation in the quantities of these proteins did exist, the overall content and relative ratios were well maintained ( Fig. 1c) , with collagen I the most abundant protein type found in the myocardial dECM. The next most abundant proteins found were collagen III, fibronectin, and laminin. This ECM protein composition is similar to what has been found in adult rat hearts 19 , indicating that the dECM produced maintains a developmental stage-appropriate tissue-specificity in regards to biochemical signaling.
Reduction of the graphene oxide (GO) was accomplished using a sodium borohydride (NaBH4)-mediated chemical reduction process in which NaBH4 removes oxygen groups from the GO lattice structure in a similar manner to hydrazine (N2H4), but without the use of a highly-toxic compound 20 . By adjusting the concentration of NaBH4 used in the reduction process, the degree of reduction of GO to rGO could be varied, and this was confirmed with the use of Raman spectroscopy ( Supplementary Fig. 1 ). As NaBH4 concentration increased, the D:G peak intensity ratio increased, indicating a removal of lattice defects and a shift towards the restoration of a nearpristine graphene lattice structure.
Examination of the structure of composite dECM-rGO hydrogels with scanning electron microscopy (SEM) showed that the hydrogels possessed a porous network similar to that of decellularized native porcine myocardium ( Fig. 1d) . Closer examination of dECM-rGO pore walls revealed that nanoscale flakes of rGO were deposited on the walls, indicating that encapsulated cells would be able to interact closely with the rGO. It is unclear, however, whether these rGO aggregates penetrated through the walls such that adjacent pores would be connected or bridged by the electroconductive material.
The mechanical properties of dECM-rGO hydrogels were examined using compressive and rheological testing. Compressive modulus was found to increase as both a function of the degree of reduction of the rGO ( Fig. 2a) and as a function of rGO content within the hydrogels (Fig. 2b) .
The average compressive moduli obtained with the hydrogels tested in this study ranged from 10.6 ± 0.3 kPa (dECM only) to 17.5 ± 0.5 kPa (dECM with 0.3% w/v 300 mM NaBH4-reduced rGO), which are comparable to the range for native myocardium 21, 22 . Hydrogel viscosity was also found to increase as rGO reduction ( Fig. 2c ) and content increased ( Fig. 2d) . Notably, all dECM-based hydrogel formulations exhibited shear-thinning properties, in which material viscosity decreased as shear rate increased. Storage (G') and loss (G") moduli were found to change in response to hydrogel composition in the same manner as before, with G' and G" values increasing as rGO reduction and content increased ( Supplementary Fig. 2) .
Dehydrated scaffolds were subjected to four-point probe measurements to determine the effect of rGO on material electroconductivity. dECM-only scaffolds were not highly conductive, with a measured average conductivity (0.0005 ± 0.0002 S/m). Increasing rGO reduction and content led to corresponding increases in hydrogel electroconductivity ( Fig. 2e, f) , with average hydrogel conductivities ranging from 0.93 ± 0.12 S/m to 3.07 ± 0.12 S/m. While these values are approximately 3-10 times greater than those reported for native myocardium 23, 24 , this could be beneficial for supporting a high degree of electrical signal propagation during the early stages of cell and tissue maturation when gap junctions have not yet been fully developed. In summary, it was demonstrated that via the nature and content of the incorporated rGO, the mechanical and electrical properties of the resultant dECM-rGO hydrogels could be tuned. It should be noted that the observed increases in stiffness due to rGO could not be decoupled from a corresponding increase in conductivity; therefore, in order to have a dECM-based hydrogel that could serve as a stiffness control in subsequent cell-based studies, dECM hydrogels crosslinked with transglutaminase (TG) were utilized. These dECM-TG hydrogels featured compressive moduli similar to that of the stiffest formulation of dECM-rGO ( Supplementary Fig. 3) , and thus fulfilled the requirement for a hydrogel that still possessed the biochemical cues of dECM, but without the enhanced electroconductivity imparted by rGO.
Cytotoxic effects from highly-conductive carbon lattice-based materials, such as graphene, graphene oxide, and carbon nanotubes, have been reported in literature 25, 26 . An assessment of the biocompatibility of dECM-rGO hydrogels, however, demonstrated that the presence of rGO had no long-term negative effects on cardiomyocyte and stromal cell viability (> 90% viable after 35 days), even at the highest concentrations used in this study ( Supplementary Fig. 4 ).
Enhanced engineered heart tissue contractile function and maturation mediated by dECM-
rGO hydrogels. Three-dimensional engineered heart tissues (EHTs) were generated by casting a mixture of hiPSC-derived cardiomyocytes, human bone marrow-derived stromal cells, and prehydrogel solution around silicone posts that enabled in situ twitch force measurements via post deflection imaging ( Fig. 3a, Supplementary Videos 1 & 2) . In these studies, collagen I hydrogel was selected as a control scaffold material that was closest in approximation to the biochemical make-up of dECM and is commonly used to fabricate 3D cardiac tissues. Additionally, the stiffest and most electroconductive dECM-rGO composition (dECM with 0.3% w/v 300 mM NaBH4 rGO) was used, and as mentioned previously, dECM-TG served as a stiffness control. EHTs were cultured over a 35-day period, with their contractile performance analyzed every 7 days. While no difference in twitch force was found in the first 7 days, a significant increase in force output was detected in dECM-rGO tissues on Day 14 (Fig. 3b) . Specifically, the dECM-rGO tissues produced twitch forces nearly twice that of the next closest group (23.61 ± 2.62 μN vs. 12.97 ± 3.00 μN, dECM-rGO vs. dECM-TG, respectively), and nearly five times that of the collagen tissues (23.61 ± 2.62 μN vs. 5.33 ± 2.36 μN). Noting this striking improvement in contractile function at Day 14, all subsequent experimental endpoints and data analyses were performed for Day 14 and Day 35 time points. dECM-rGO tissues continued to produce greater twitch forces compared to the other tissue groups over the entire culture period, with dECM-TG tissues consistently generating the next greatest force output, followed by dECM-only tissues, and lastly by collagen tissues.
However, it was interesting to observe that at Day 28 and Day 35, it appeared that the advantage in force generation by dECM-rGO tissues was beginning to diminish, with dECM-TG and dECM tissues producing nearly identical twitch forces (approximately 45 μN). Meanwhile, force output of the collagen tissues had essentially plateaued by Day 28 to 28.99 ± 1.37 μN. Twitch power generated by EHTs followed a similar trend, with dECM-rGO tissues producing greater power at both Day 14 and Day 35 while no significant difference was found between dECM and dECM-TG tissues at the latter time point ( Supplementary Fig. 5 ).
In examining the contractile kinetics of the EHTs, it was found that not only did the dECM-rGO tissues outperform the rest in terms of twitch force generation, but were also able both to reach maximal force ( Fig. 3c ) and relax to 90% force ( Fig. 3d ) at a faster rate per contraction, thereby attaining significantly greater contraction velocities ( Fig. 3e) . Notably, there was no significant difference in times to peak and 90% relaxation between Days 14 and 35 for dECM-rGO tissues, while all other tissue groups displayed improvements in these metrics over time.
Additionally, while the contraction kinetics of dECM and collagen tissues were comparable to each other at Day 14, by Day 35, dECM tissues were outperforming their collagen counterparts.
With the observed enhancement of EHT contractile performance due to dECM-rGO hydrogel scaffolds, the expression of several genes that code for cardiomyocyte contractionmediating proteins was analyzed and compared to hiPSC-derived cardiomyocytes grown as monolayers on tissue culture polystyrene (TCPS) as controls. Expression of MYH7, which codes for β-myosin heavy chain (β-MHC), was significantly more elevated in dECM-rGO tissues on Day 14 ( Fig. 3f ). MYH7 expression was significantly increased for all groups at Day 35, but expression levels in other tissues were still lower than those seen in the dECM-rGO group. Similar trends were observed for TNNT2, or cardiac troponin T (cTnT), although in this case both dECM-TG and dECM-rGO tissues had greater expression levels at both time points compared to the others (Fig.   3g ). Upregulation of these genes corresponded well with the collected twitch force data, as cTnT and β-MHC regulate the force generation capacity of cardiomyocytes and are considered late-stage markers of cardiac development [27] [28] [29] . Troponin I is another critical component of the myocyte contractile machinery, and a comparison of troponin I isoforms can also shed light on the maturation state of cardiomyocytes, as cells with a fetal or neonatal phenotype will largely express TNNI1 (slow skeletal TnI/ssTnI), while adult cardiomyocytes will exclusively express TNNI3 (cardiac TnI/cTnI) 5, 30, 31 . Thus, the significantly higher ratio of expression of TNNI3 to TNNI1 in dECM-rGO tissues at both time points indicates that this hydrogel composition enhances the maturation of these tissues, which likely is an important driver of improved contractile function ( Fig. 3h) . Additionally, although there is no significant difference in TNNI3:TNNI1 between dECM and dECM-TG tissues, both possess a greater amount of the cardiac isoform than the collagen and TCPS controls. At both time points, the expression levels of titin (TTN), the protein responsible for muscle elasticity, were comparable between dECM-TG and dECM-rGO, which were in turn greater than that in dECM and collagen ( Fig. 3i) . Furthermore, the ratio of the N2B to N2BA isoforms of titin was significantly higher in dECM-rGO tissues at both Day 14 and Day 35, another indication that the maturation state of these cardiomyocytes was improved by the composite hydrogel ( Fig. 3j) . Indeed, the increased presence of the N2B isoform in adult myocardium and resulting increase in passive stiffness is what allows for rapid ventricular recoil 32 , which correlates well with the observed decrease in relaxation time in dECM-rGO tissues.
Sarcomeres are the basic contractile unit of striated muscle and their structural properties directly impact force production 33 . As such, EHTs were sectioned and immunostained for sarcomeric α-actinin to assess how sarcomere development was influenced by scaffold material composition ( Fig. 4a) . Sarcomeres were shortest in collagen tissues (1.78 ± 0.01 μm) and progressively lengthened as the hydrogel scaffolds were more biochemically diverse, stiffer, and electroconductive, with the longest sarcomeres (2.11 ± 0.02 μm) found in dECM-rGO tissues ( Fig.   4b ). For comparison, sarcomeres in adult human cardiomyocytes are reported to be approximately 2.2 μm in length 34 , while immature cardiomyocytes cultured on standard 2D substrates typically have sarcomeres that are only about 1.5 -1.65 μm long 35 . In addition to sarcomere length, the lateral alignment of adjacent sarcomeres plays an important role in contraction synchronicity and overall force output. Sarcomere register is typically assessed as a function of Z-band width, where cardiomyocytes capable of generating more twitch power feature wider Z-bands 36 . Similar to the trend observed with sarcomere length, Z-bands were shortest in collagen tissues (3.12 ± 0.12 μm) and widest in dECM-rGO tissues (3.92 ± 0.13 μm), although statistical difference was only found for the dECM-rGO group (Fig. 4c ).
Enhanced EHT electrophysiological function mediated by dECM-rGO hydrogels. Calcium
plays an important role in regulating the excitation-contraction coupling processes that are required for proper cardiac function. To determine the impact of scaffold material on the Ca 2+ -handling capabilities of EHTs, a Ca 2+ -sensing fluorescent dye was used to monitor changes in intracellular Ca 2+ levels during contractions ( Fig. 5a) . At both Day 14 and Day 35, the normalized average change in fluorescence intensity was found to be significantly greater in dECM-rGO tissues versus its dECM counterparts, an indication of increased Ca 2+ flux and thus a greater concentration of calcium present in these tissues each contraction cycle ( Fig. 5b) . Additionally, while Ca 2+ transients increased over time for dECM-rGO tissues, transient levels remained relatively unchanged for dECM tissues. An examination of expression levels for ion channels involved in maintaining cytosolic calcium homeostasis, CACNA1C (L-type Ca 2+ channel CaV1.2) and ATP2A2 (Ca 2+ -ATPase; SERCA2), shows significantly elevated expression of both genes in dECM-rGO tissues compared to all other tissue types, with ATP2A2 expression further increased on Day 35 ( Fig. 5c, d) .
To further characterize the electrophysiological function of these EHTs, a voltage-sensing fluorescent dye was used to investigate action potential behavior ( Fig. 5e ). Action potential duration at 90% repolarization (APD90), commonly used as an analog for QT interval, was observed to be significantly longer in dECM-rGO tissues (488 ± 21 ms) than in dECM tissues (343 ± 11 ms) at Day 14. At Day 35, however, both tissues had similar APD90 values at 477 ± 25 ms and 504 ± 12 ms, for dECM and dECM-rGO, respectively ( Fig. 5f) . For comparison, QT intervals in adult humans are generally reported to be in the 350 -460 ms range 37 . In examining the expression of several K + channels that contribute to the plateau phase of cardiomyocyte action potentials, it was found that KCNH2 (human ether-a-go-go-related-gene; hERG) ( Fig. 5g ) and KCNE1 ( Supplementary Fig. 6a ) were upregulated in dECM-rGO tissues by almost 3-fold at both Day 14 and Day 35, with no significant change in expression between the two time points.
Meanwhile, expression of KCNJ2 (KIR2.1) ( Fig. 5h ) and KCNQ1 (Supplementary Fig. 6b ) was not significantly different between tissues generated with dECM-based hydrogels; however, expression levels were much greater than that of the collagen and TCPS controls. Moreover, expression of these two genes was found to increase significantly over time for all three of the dECM-based hydrogel groups. The variations in the expression levels of these particular K + channels (along with the increased CACNA1C exoression) may explain the observed trends in APD90. The significant upregulation of KCNH2 and KCNE1 in dECM-rGO tissues could account for its longer APD90 at Day 14. Then, as additional K + channels such as KCNJ2 and KCNQ1 become more numerous in dECM tissues over time, APD90 values begin to equalize, as seen with the Day 35 analysis. In addition to an increase in APD90 mediated by dECM-rGO, the time to peak depolarization was significantly reduced at Day 14 in these tissues (Fig. 5i ). Similar to the trend observed for APD90, there was no significant difference in time to peak depolarization between dECM and dECM-rGO tissues at Day 35. Expression of SCN5A, which codes for the voltage-gated Na + channel NaV1.5 that is responsible for mediating membrane depolarization in cardiomyocytes, was found to be much higher in dECM-rGO tissues at Day 14, although no difference in expression was found amongst the three dECM-based tissues at Day 35 despite an overall upregulation across these groups (Fig. 5j) . Like with the K + channel expression patterns, this result likely explains the comparable depolarization rates between dECM and dECM-rGO tissues that were seen at the later time point.
Data collected from the voltage-sensing dye, FluoVolt, was also used to calculate the longitudinal conduction velocity (CVL) in EHTs. At both time points, conduction velocity was significantly greater in dECM-rGO tissues than in their dECM counterparts, with a peak CVL of 35.4 ± 2.3 cm/s recorded at Day 35 (Fig. 5k) , which approaches the mean conduction velocity of isolated human left ventricular myocardium (49.8 ± 3.8 cm/s) 38 . Since electrical signal transmission between cardiomyocytes has been shown to be closely associated with connexin 43 (Cx43) gap junction formation 39 , the expression of the gene that codes for this protein was examined. Indeed, GJA1 expression was significantly greater in dECM-rGO tissues, although no difference in expression levels was seen between the early and late time points in all tissues ( Fig.   5l ).
Regulation of transcription factor expression by hydrogel composition. Transcription factors
are known to play an important role in determining cell fate and tissue morphogenesis. In developing cardiac tissues, Nkx2.5 and GATA4 are highly expressed in the pre-cardiac mesoderm and in cardiac progenitor cells, and numerous gain/loss of function studies have shown that these two factors work in concert to drive the cardiomyocyte differentiation process [40] [41] [42] . RT-qPCR analysis of NKX2.5 and GATA4 expression in EHTs at Day 14 showed that although all four of the tested hydrogel scaffolds induced higher expression levels than what were seen in 2D cultured cells, only dECM-rGO tissues had a significantly greater expression level than collagen controls ( Fig. 6) . However, as EHTs became more mature over time, the expression of both genes saw a significant decrease. This reduction in expression was found to be closely tied to the type of scaffold material used; as the microenvironmental cues became more complex, the decrease in expression became greater. In fact, TCPS actually elicited an increase in expression in cardiomyocytes. These results serve to illustrate the impact on maturation rate that is elicited by 3D dECM-based hydrogels, and by dECM-rGO in particular.
Bioprinting a microphysiological drug screening platform with dECM-rGO bioink. As noted previously, dECM and dECM-rGO hydrogels exhibited shear-thinning behavior in response to increases in strain rate. This type of viscoelastic property makes these hydrogels well-suited to applications such as bioprinting where it is desirable to have a material that can be easily extruded, while maintaining the capacity to quickly reform and hold a structure post-extrusion. Using a dualextruder bioprinter, a multi-material design was developed in which hydrogels could be utilized as a bioink for generating 3D cardiac tissues in a high-throughput manner while taking advantage of the beneficial effects on tissue maturation that dECM-rGO could offer (Fig. 7a) . In this design, pairs of vertical posts comprised of polycaprolactone (PCL) were printed to serve as anchor points for tissues and to induce anisotropic cellular alignment, while Pluronic F-127 was used to print temporary wells around these posts to aid in tissue formation during the first 24 hrs.
Using this platform, cardiac tissues were printed with dECM and dECM-rGO bioinks and cultured for 14 and 35 days before being subjected to a dose response study with cisapride.
Cisapride is a histamine receptor antagonist later discovered to be a potent hERG channel blocker that induces QT interval prolongation and potentially lethal Torsade de Pointes (TdP). This arrhythmogenic property was not detected using conventional preclinical screening assays, and the arrhythmogenic complications led to its withdrawal from market [43] [44] [45] . Fluorescent imaging of FluoVolt dye was once again used to assess cisapride's impact on tissue APD90 length and beat interval regularity across a large range of concentrations. At Day 14, it was found that dECM and dECM-rGO tissues responded significantly differently to increasing cisapride concentrations ( Fig.   7b ). While both tissue types exhibited APD90 prolongation and an increase in ΔBI, the IC50 values differed by an order of magnitude ( Fig. 7c) . dECM-rGO tissues responded to cisapride at clinically relevant concentrations, with IC50 values (APD90: 2.5 ± 1.3 nM; ΔBI: 8.6 ± 1.2 nM) that were very similar to its effective therapeutic plasma concentration (ETPC) of 2.6 -4.9 nM 46 . On the other hand, dECM tissues had IC50 values that were much higher at 61.8 ± 1.4 nM and 73.4 ± 1.4 nM for APD90 and ΔBI, respectively. Surprisingly, there was no significant difference in drug response between the dECM and dECM-rGO tissues at Day 35, with best-fit dose response curves for percent change in APD90 and ΔBI identical between the two tissue types (Supplementary Fig.   7a ). However, IC50 values for both dECM (APD90: 2.0 ± 1.3 nM; ΔBI: 7.3 ± 1.2 nM) and dECM-rGO tissues (APD90: 1.8 ± 1.4 nM; ΔBI: 3.1 ± 1.3 nM) were representative of native cardiac tissue response when exposed to cisapride (Supplementary Fig. 7b ).
Discussion
The results of this study demonstrate the ability to generate a library of bioactive and electroactive hydrogels through the doping of dECM with rGO, and the capability of these hybrid hydrogels to improve the functional phenotype of engineered cardiac tissues such that they can produce physiological responses to external stimuli. The electrical and mechanical properties of dECM-rGO hydrogels were modulated by the reduction of GO to a more graphene-like sp 2 hybridized lattice structure that imparts high conductivity and mechanical strength 47 , and this phenomenon has been observed in other instances where the addition of graphene or rGO to polymer matrices also resulted in corresponding increases in modulus and conductivity [48] [49] [50] [51] . While the use of pristine graphene would have likely resulted in hydrogels with even greater electroconductivities and stiffnesses, the relatively hydrophobic nature of graphene compared to rGO does not lend itself well to homogenous dispersion within aqueous matrices, risking tissue-wide inconsistencies in cellular response. Furthermore, residual oxygen-containing groups in rGO could induce the spontaneous adsorption of proteins and thereby act as depots for biomolecules that contribute to cell differentiation and development 52 . Although transglutaminase-crosslinked dECM was only used as a stiffness control in this study, it is plausible that the modulus of dECM-rGO hydrogels could be further increased with the addition of transglutaminase, thereby providing yet another degree of tunability to the hybrid material. This could prove to be an immensely useful tool for certain applications, such as the modeling of fibrotic and hypertrophic ventricular myocardium, in which a stiffer cell microenvironment is desired 53 .
In terms of twitch force production and contraction kinetics, the performance of dECMonly and collagen tissues were comparable at the early time point, and this was also reflected in the expression profiles of the selected genes. However, as time went on, the dECM appeared to confer a distinct advantage on inducing maturation, with notable gains in functional output and the expression of genes encoding titin and cTnI. dECM-mediated improvements in electrophysiological function were observed to occur even sooner in culture, with the greatest effect seen on K + and Na + channel gene expression. These effects can be attributed to the fact that although dECM hydrogels are a homogenization of many intra-tissue niches and the decellularization process slightly alters native tissue protein composition, compared to single component biomaterials like collagen, dECM-based materials are unique in that they are still capable of presenting a cell microenvironment with a wider spectrum of tissue-specific biochemical cues that are essential for supporting proper development. Indeed, similar findings have been reported in which dECM scaffolds have been found to exert enhanced differentiation and development on a variety of tissue types in vitro 18, [54] [55] [56] , as well as pro-regenerative effects on skeletal muscle [57] [58] [59] and myocardium 60, 61 in vivo.
Like most other naturally-derived scaffold hydrogels, however, there is a modulus mismatch between dECM and native tissue. The proper tuning of matrix stiffness has proven to be a critical factor in successfully engineering cardiac tissues, as prior studies have found that the development of cardiomyocyte contractile function and striation is significantly improved in microenvironments that closely approximate myocardial stiffnesses 22, 36, 62 . This is somewhat unsurprising, as there is a large body of evidence that implicates the role of integrins in translating biomechanical signals to determine cell fate and that myofibril assembly starts at these integrin adhesion sites [63] [64] [65] . The results presented here are consistent with those findings, as the stiffer dECM-TG and dECM-rGO hydrogels generated tissues that produced greater twitch forces and velocities, and an increased expression of TNNT2, TNNI3, TTN, and N2B. Sarcomere formation was also improved by a corresponding increase in matrix stiffness. Surprisingly, the relative expressions of the various ion channels and GJA1 in dECM and dECM-TG tissues were statistically comparable, which suggests that matrix stiffness appears to have a limited effect on regulating this subset of electrophysiological development. Further examination of integrinmediated signaling pathways is clearly needed; however, a study conducted with neonatal rat ventricular cardiomyocytes showed that even though substrates with biomimetic stiffnesses induced increased action potential duration and calcium flux, L-type Ca 2+ channel expression in these cells was unchanged 66 .
Based on the stark improvement of EHT contractile and electrophysiological function and increased expression of associated developmental markers within these tissues, it is evident that rGO exerts a profound effect on multiple aspects of hiPSC-derived cardiomyocyte maturation.
While there is an abundance of examples in which electroconductive scaffolds have been shown to enhance the maturation and function of cardiomyocytes 13, 48, [67] [68] [69] [70] , the mechanisms and signaling pathways mediated by these types of materials have yet to be fully elucidated. In almost all reported cases, however, the most significant improvements in performance were in parameters related to electrical coupling, such as Cx43/GJA1 expression, which has a direct correlation to increased conduction velocities. This implies that although electroconductivity still plays a role in upregulating other cardiac-specific proteins and transcription factors, it appears that the largest impact is on promoting electrophysiological development of these cells. The recent discovery that cells cultured on graphene exhibited an enrichment of the cholesterol content in their membranes raises interesting questions on what downstream effects this would potentially regulate 71 . For example, since membrane cholesterol has been shown to promote G protein-coupled receptor (GPCR) activity 72 , an increase in cholesterol could result in a corresponding increase in the activity of GPCRs, such as sphingosine 1-phosphate receptor-1, that contribute to normal cardiac development 73 . It has also been found that gap junctions like Cx43 and KV channels like hERG localize to cholesterol-rich membrane domains, and that alteration of this membrane lipid environment can modulate the function of these proteins [74] [75] [76] . Furthermore, an increase in plasma membrane cholesterol content has been shown to increase Ca 2+ flux through membrane calcium channels in a number of different cell types, including cardiomyocytes [77] [78] [79] .
Thus, with the synergistically beneficial combination of biochemical, mechanical, and electroconductive cues offered by dECM-rGO hydrogels, a more pronounced maturation response in cardiomyocytes was observed than in tissues generated with only collagen or dECM. Improvements in some aspects of maturation were also evident when compared to other 3D human stem cell-based cardiac tissue engineering approaches that used non-conductive hydrogel scaffolds with a limited spectrum of tissue-specific biochemical cues 6, 80, 81 . However, it should be noted that the expression of some genes associated with the cardiomyocyte contractile machinery, namely MYH7 and TNNT2, was found to be relatively lower than those in which engineered tissues underwent cyclic physical conditioning 7, 8 , suggesting that if dECM-rGO scaffolds were to be utilized in similar bioreactor systems, further gains in contractile phenotype maturation could be achieved.
A significant limitation of current preclinical screening techniques for drug-induced cardiotoxicity is their inability to provide accurate predictability, leading to incidences of false positives or negatives, increases in drug development costs, and unnecessary risk to patients. The reliance on animal models and non-human cell lines has contributed to this problem due to mismatches in pharmacokinetics and physiology between species 82 , so a shift towards the utilization of 3D humanized in vitro tissue models is a promising first step. However, not only do these approaches suffer from the aforementioned issues with phenotypic immaturity, but they are also hampered by low throughput and fabrication variability. The emergence of bioprinting and additive manufacturing as tissue fabrication methods offers a potential solution to these drawbacks as these techniques allow for the precise deposition and patterning of multiple biomaterials in a reproducible and automated fashion 83 . In the design developed in this study each post pair and well was a single defined unit, and this imparted increased modularity and versatility compared to more conventional grid designs 18, 84 as it could be adapted for a variety of layouts to increase or decrease desired experimental throughput. For example, while a 5 tissue per well of a 6-well plate format was used, the same design could be used to print a single tissue per well in a 24-well or 48-well plate. When used with dECM-rGO bioinks, bioprinting was therefore able to produce larger numbers of more mature cardiac tissues in less time and in a format that still allowed for conventional image-based analysis of changes in electrophysiological function. While current hardware limitations do not allow for a level of throughput commensurate with existing systems such as microelectrode arrays (MEAs) 85 , the ability to utilize 3D tissues instead of 2D monolayers is still an advantageous aspect of this approach.
Based on the vast difference in expression of the hERG channel coding gene KCNH2
between dECM and dECM-rGO tissues, it is perhaps unsurprising that even after only 14 days of culture, cisapride induced abnormal APD90 prolongation and beat intervals in dECM-rGO tissues at physiological concentrations. In comparison to previously reported drug screening platforms based on hiPSC-derived cardiomyocytes 85, 86 , whole animal models 87 , and in silico simulations 88 , our platform was able to produce IC50 values for cisapride or similar hERG channel blockers that were within the same order of magnitude as ETPC. What was surprising, however, was the indistinguishable difference in response of the dECM and dECM-rGO tissues to cisapride after 35 days of culture despite there still being a significant gap in KCNH2 expression at this time point.
This result could indicate that as time progressed, dECM scaffolds were able to induce further development of other ion channels that were not examined in this study and that these channels contributed to an overall maturation state that allowed these tissues to behave physiologically to this particular drug. In fact, other studies have suggested that the onset of TdP cannot be solely explained by the blockade of a single current 89 . However, when combined with the collected twitch force data, the results of this cisapride assay could also serve as further evidence of the role dECM-rGO hydrogels play in accelerating the maturation of engineered cardiac tissues to the point that even though the developmental stage has not yet reached a fully adult-like phenotype, these tissues are still mature enough to produce useful data in drug screening and disease modeling applications.
To the end user, this could potentially provide significant advantages to cost and throughput, as tissues would only need to be maintained for a shorter duration of time before use.
In summary, the findings of this study illustrate the synergistic impact that the microenvironmental cues present in dECM-rGO hydrogels had on promoting the functional maturation of engineered cardiac microphysiological systems. Not only did this biomaterial induce significant improvements in several metrics of cardiac function, these developmental gains were translated into clinically-relevant physiological responses suitable for downstream applications.
Furthermore, the tunability of these hybrid hydrogel's properties and demonstrated applicability as a bioink for 3D bioprinting enable it to be a versatile tool for answering multiple biological questions. The ease in which two materials with largely disparate characteristics could be combined into a single composite demonstrates the potential for other adjuncts that could be incorporated into these hydrogels, such as soluble or tethered factors or other synthetic nanomaterials that could be used to further enhance overall material functionality. Fig. 8 ).
Stromal cell source and culture. HS-27A human bone marrow-derived stromal cells (ATCC)
were cultured and maintained in high-glucose DMEM (Invitrogen) supplemented with 10% fetal bovine serum until used to generate tissues. Engineered heart tissue platform fabrication. The design and fabrication of the hardware utilized for both generating the engineered heart tissues (EHTs) and measuring forces in situ has been previously described 93, 94 . In brief, post pair arrays were fabricated by pouring uncured polydimethylsiloxane (PDMS; Sylgard 184, Dow Chemical) at a 10:1 base to curing agent ratio into an acrylic mold. A glass capillary tube was inserted into one post of each pair to impart rigidity to that post. Molds were then allowed to de-gas prior to being placed into a 65°C oven overnight to cure the PDMS. Cured post pair arrays were then removed from the mold. Arrays were fabricated in sets of six pairs, with each post 12.5 mm long and 1.5 mm in diameter and featuring a cap structure 0.5 mm thick and 2 mm in diameter to assist with tissue attachment. Post-to-post spacing was 8 mm. Wells for tissue casting were fabricated by pouring approximately 1 mL of PDMS into the wells of a 24-well culture plate before inserting custom 3D printed molds that would form rectangular wells that were 12 mm x 4 mm x 4mm (length x width x depth). After curing the PDMS overnight, molds were removed. All fabricated hardware was sterilized with 70% v/v ethanol and UV light prior to use.
Generating engineered heart tissue constructs. hiPSC-CMs and HS-27A stromal cells were mixed in hydrogel pre-gel solutions at cell densities of 20 x 10 6 cells/mL and 5 x 10 6 cells/mL, respectively. 70 μL of this cell-hydrogel mixture was then pipetted into each casted PDMS well, after which PDMS post arrays were positioned upside-down into the wells, ensuring that each post tip was properly immersed in solution. The 24-well plate was then placed into an incubator at 37°C and 5% CO2 for approximately 60 min, after which the hydrogels had crosslinked and 1 mL of Tissues for calcium imaging were paced at 0.67 Hz with field stimulation generated by electrodes placed at each end of the tissue, and fluorescence intensity over time was quantified using NIS Elements software (Nikon) and used to calculate ΔF/F0 values. For action potential imaging, tissues were paced at 1.5 Hz and fluorescence intensity from the FluoVolt dye was again quantified using NIS Elements. APD90 and time to peak values were then calculated using a custom MATLAB script that removed motion artifacts from the analyses 94 . Longitudinal conduction velocity (CVL) was calculated by measuring the time delay in the onset of depolarization at two regions of interest that were at opposite ends of the tissue's long axis and were a known distance apart.
Gene expression analysis. The relative expression levels of selected genes were obtained using reverse-transcription quantitative polymerase chain reaction (RT-qPCR) analyses. After 14 and 35 days of culture, tissues were gently removed from posts and each tissue was placed into an Eppendorf tube containing a 100 μL solution of 2 mg/mL proteinase K in PBS. Tubes were then heated at 56°C for 10 mins before 350 μL of lysis buffer was added. The mixture was vortexed until clear and 250 μL of ethanol was added to the tubes. RNA was then subsequently isolated from this solution by using the RNeasy Plus RNA extraction kit (QIAGEN) according to the manufacturer's protocol. cDNA was then synthesized from the isolated RNA with a reverse transcription kit (iScript Reverse Transcription Supermix, Bio-Rad). Quantity and purity of collected RNA and synthesized cDNA was determined by 260/280 nm absorbance. Synthesized cDNA was then analyzed with qPCR using SYBR green (Bio-Rad) as the reporter and primers used as provided from the manufacturer (Bio-Rad). Amplicon context sequences for these primers are provided in Supplementary Table 1 , and primer sequences for N2B and N2BA are provided in Supplementary Table 2 . Relative gene expression was calculated using the comparative Ct method, where GAPDH was designated as the housekeeping gene and age-matched hiPSC-derived cardiomyocytes cultured on tissue culture polystyrene (TCPS) with the same ratio of HS27A stromal cells as used in the EHTs were used as controls. Each sample was run in triplicate for each gene. Functional response of these tissues to administered drug was assessed using FluoVolt dye in conjunction with live-tissue imaging as described above. Change in beat interval (ΔBI) was determined by measuring that duration of elapsed time between individual beats (the beat interval) and calculating the difference in this interval from one beat to the next. APD90 values were calculated as described above. Best-fit dose response curves were calculated using GraphPad Prism software. Drug concentration values were first transformed to a log scale and APD90 or ΔBI values were normalized such that the lowest value was set at 0% and the largest value at 100%.
Immunofluorescent
Finally, the normalized data was fit to a non-linear dose response curve using a least squares fit.
Statistical analyses.
Unless otherwise noted, all quantitative data is presented as means ± standard error with a minimum of n = 6. One-way ANOVA with a Tukey's post-hoc test was used to analyze data sets that included more than two experimental groups, while a Student's t-test was used to compare data sets looking at only two variables. In all presented analyses, p < 0.05 was considered significant and n is defined as a separate tissue.
Figure 1. Materials synthesis and structural-biochemical characterization.
(a) Composite hydrogels are synthesized using a parallel process. dECM (top) is produced by first isolating and mincing left ventricular myocardium from freshly-harvested porcine hearts. Minced tissue is decellularized using a combination of detergents before being lyophilized. rGO (bottom) is produced by reducing GO with NaBH4 for 1 hr before filtration and resuspension in dH2O. The two components are combined with HCl and pepsin to form a pre-gel solution that can then be formed into hydrogels by incubation at 37°C. (b) LC/MS analysis of dECM indicates that while some batch-to-batch variation occurs, (c) overall protein composition is relatively well maintained across produced batches. **p < 0.01, ***p < 0.001 (One-way ANOVA with a Tukey's post-hoc test, n = 6). (d) SEM imaging of dECM-rGO hydrogels reveals a porous structure similar to that of decellularized myocardium. Deposition of rGO flakes (white arrows) on the pore walls can be observed. 
